Researchers have identified a protein called “Mitch” that could become a promising new target for obesity treatment. In laboratory studies, disabling Mitch in human cells increased fat burning, boosted energy expenditure, and prevented immature cells from developing into fat-storing cells. Supporting these findings, mice lacking the protein remained lean, showed greater athletic performance, and were resistant to obesity despite conditions that normally promote weight gain. The discovery suggests Mitch acts as a key regulator of fat metabolism and storage. While the research is still in its early stages, it opens the door to future therapies aimed at treating obesity by increasing the body’s natural ability to burn fat.
Read more at ScienceDaily